JoinClinicalTrials.com

Results

Hot

Post your clinical trial on JoinClinicalTrials.com

Ellijay, Georgia 30536
United States

Post your clinical trial on JoinClinicalTrials.com to reach thousands of viewer daily. Our Clinical Trial Listings have consistently proven to be an ...

• Pharmacogenomics Testing in Directing the Optimal Use of Supportive Care Medications in Patients With Stage III-IV Cancer

  NCT04067960

  Conditions:   Anatomic Stage III Breast Cancer AJCC v8;   Anatomic Stage IIIA Breast Cancer AJCC v8;   Anatomic Stage IIIB Breast Cancer AJCC v8;   Anatomic Stage IIIC Breast Cancer AJCC v8;   Anatomic Stage IV Breast Cancer AJCC v8;   Clinical Stage III Cutaneous Melanoma AJCC v8;   Clinical Stage IV Cutaneous Melanoma AJCC v8;   Health Care Provider;   Malignant Brain Neoplasm;   Malignant Genitourinary System Neoplasm;   Pathologic Stage III Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIA Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIB Cutaneous Melanoma AJCC v8;   Pathologic Stage IIIC Cutaneous Melanoma AJCC v8;   Pathologic Stage IV Cutaneous Melanoma AJCC v8;   Prognostic Stage III Breast Cancer AJCC v8;   Prognostic Stage IIIA Breast Cancer AJCC v8;   Prognostic Stage IIIB Breast Cancer AJCC v8;   Prognostic Stage IIIC Breast Cancer AJCC v8;   Prognostic Stage IV Breast Cancer AJCC v8;   Stage III Colorectal Cancer AJCC v8;   Stage III Ovarian Cancer AJCC v8;   Stage III Pancreatic Cancer AJCC v8;   Stage III Prostate Cancer AJCC v8;   Stage IIIA Colorectal Cancer AJCC v8;   Stage IIIA Ovarian Cancer AJCC v8;   Stage IIIA Prostate Cancer AJCC v8;   Stage IIIB Colorectal Cancer AJCC v8;   Stage IIIB Ovarian Cancer AJCC v8;   Stage IIIB Prostate Cancer AJCC v8;   Stage IIIC Colorectal Cancer AJCC v8;   Stage IIIC Ovarian Cancer AJCC v8;   Stage IIIC Prostate Cancer AJCC v8;   Stage IV Colorectal Cancer AJCC v8;   Stage IV Ovarian Cancer AJCC v8;   Stage IV Pancreatic Cancer AJCC v8;   Stage IV Prostate Cancer AJCC v8;   Stage IVA Colorectal Cancer AJCC v8;   Stage IVA Ovarian Cancer AJCC v8;   Stage IVA Pancreatic Cancer;   Stage IVA Prostate Cancer AJCC v8;   Stage IVB Colorectal Cancer AJCC v8;   Stage IVB Ovarian Cancer AJCC v8;   Stage IVB Pancreatic Cancer;   Stage IVB Prostate Cancer AJCC v8;   Stage IVC Colorectal Cancer AJCC v8
  Interventions:   Procedure: Biospecimen Collection;   Other: Genetic Testing;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
  Sponsors:   Mayo Clinic;   National Cancer Institute (NCI)
  Recruiting
• ALateral Flow Assay to Detect QSOX1 Peptide in Patients With or at Risk for Pancreatic Cancer

  NCT04064034

  Conditions:   Pancreas Cancer;   Pancreas Cyst
  Intervention:   Other: Lateral Flow Assay (LFA)
  Sponsor:   Mayo Clinic
  Recruiting
• Physiological Adaptations to Simulated Intermittent Altitude on Human Health and Performance

  NCT03743610

  Condition:   Altitude Hypoxia
  Interventions:   Other: Simulated altitude;   Other: Placebo simulated altitude
  Sponsor:   Mayo Clinic
  Recruiting
• Lidocaine Jelly for Pain Control During Mohs Surgery

  NCT03595449

  Conditions:   Pain;   Satisfaction, Consumer
  Interventions:   Drug: Lidocaine jelly;   Drug: Surgilube
  Sponsor:   Mayo Clinic
  Recruiting
• Minimally-Invasive Detection of Barrett's Esophagus and Barrett's Esophagus Related Dysplasia/Carcinoma

  NCT02560623

  Condition:   Barrett's Esophagus
  Intervention:   Device: Sponge capsule
  Sponsors:   Mayo Clinic;   Exact Sciences Corporation
  Recruiting
• Evaluation of the Precision and Sensitivity of Tilmanocept Uptake Value (TUV) on Tc 99m Tilmanocept Planar Imaging

  NCT03938636

  Condition:   Rheumatoid Arthritis
  Intervention:   Drug: TC99m-tilmanocept
  Sponsor:   Navidea Biopharmaceuticals
  Recruiting
• Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

  NCT03642210

  Condition:   Menorrhagia
  Intervention:   Combination Product: Levonorgestrel 52 mg intrauterine system
  Sponsor:   Medicines360
  Recruiting
• A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

  NCT02565511

  Condition:   Alzheimer's Disease
  Interventions:   Biological: CAD106 Immunotherapy;   Other: Placebo to CAD106;   Drug: CNP520;   Other: Placebo to CNP520
  Sponsors:   Novartis Pharmaceuticals;   Banner Alzheimer's Institute;   National Institute on Aging (NIA);   Alzheimer's Association;   Amgen
  Recruiting